Ginkgo Bioworks Holdings Inc (DNA)
0.7777
-0.07
(-8.05%)
USD |
NYSE |
Apr 25, 16:00
0.79
+0.01
(+1.58%)
Pre-Market: 05:37
Ginkgo Bioworks Holdings Total Liabilities (Quarterly): 568.19M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 568.19M |
| September 30, 2023 | 773.71M |
| June 30, 2023 | 788.41M |
| March 31, 2023 | 809.62M |
| December 31, 2022 | 803.04M |
| September 30, 2022 | 430.96M |
| Date | Value |
|---|---|
| June 30, 2022 | 427.16M |
| March 31, 2022 | 443.68M |
| December 31, 2021 | 503.61M |
| September 30, 2021 | 532.62M |
| December 31, 2020 | 205.10M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
205.10M
Minimum
Dec 2020
809.62M
Maximum
Mar 2023
571.46M
Average
532.62M
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
| Agenus Inc | 462.30M |
| Teladoc Health Inc | 2.066B |
| Sarepta Therapeutics Inc | 2.405B |
| Ultragenyx Pharmaceutical Inc | 1.216B |
| Apellis Pharmaceuticals Inc | 594.21M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.665B |
| Shareholders Equity (Quarterly) | 1.097B |
| Current Ratio | 6.113 |